Allworth Financial’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4K | Sell |
195
-37
| -16% | -$1.97K | ﹤0.01% | 2866 |
|
|
2025
Q1 | $9.51K | Hold |
232
| – | – | ﹤0.01% | 2439 |
|
|
2024
Q4 | $5.81K | Hold |
232
| – | – | ﹤0.01% | 2685 |
|
|
2024
Q3 | $6.66K | Hold |
232
| – | – | ﹤0.01% | 2441 |
|
|
2024
Q2 | $6.21K | Hold |
232
| – | – | ﹤0.01% | 2414 |
|
|
2024
Q1 | $5.86K | Sell |
232
-9
| -4% | -$227 | ﹤0.01% | 2343 |
|
|
2023
Q4 | $5.63K | Sell |
241
-495
| -67% | -$11.6K | ﹤0.01% | 2227 |
|
|
2023
Q3 | $37.2K | Hold |
736
| – | – | ﹤0.01% | 1227 |
|
|
2023
Q2 | $34.4K | Hold |
736
| – | – | ﹤0.01% | 1260 |
|
|
2023
Q1 | $28.2K | Hold |
736
| – | – | ﹤0.01% | 1285 |
|
|
2022
Q4 | $40.3K | Hold |
736
| – | – | ﹤0.01% | 1094 |
|
|
2022
Q3 | $25K | Buy |
736
+536
| +268% | +$18.2K | ﹤0.01% | 1201 |
|
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 1976 |
|
|
2022
Q1 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 1694 |
|